Case reports and the fight against cancer by Dib, Elie G et al.
BioMed  Central
Page 1 of 2
(page number not for citation purposes)
Journal of Medical Case Reports
Open Access Editorial
Case reports and the fight against cancer
Elie G Dib*1, Michael R Kidd2 and Deborah C Saltman3
Address: 1Sanford Cancer Center, University of South Dakota, 1020 West 18th Street, Sioux Falls, SD 57104, USA, 2Discipline of General Practice, 
The University of Sydney, 37A Booth Street, Balmain, Sydney, NSW 2041, Australia and 3Institute of Postgraduate Medicine, Brighton and Sussex 
Medical School, Mayfield House, University of Brighton, Falmer, Brighton BN1 9PH, UK
Email: Elie G Dib* - dibe@sanfordhealth.org; Michael R Kidd - michael@gp.med.usyd.edu.au; Deborah C Saltman - D.Saltman@bsms.ac.uk
* Corresponding author    
Abstract
Some of the earliest case reports describing individual patients afflicted with cancer can be traced
all the way back to the papyrus records of Ancient Egyptian medicine of approximately 1600 B.C..
Throughout the centuries physicians have continued the practice of writing case reports. Case
reporting has provided significant advances in the knowledge of cancer on several fronts. It is
without question that case reports do not replace well designed randomized clinical trials in
advancing medical knowledge about cancerous diseases. However, case reports have their unique
role in evidence-based medicine and often constitute the first line of evidence. This editorial
reviews the many useful aspects of case reports and describes specific reports known to have
revolutionized cancer management. Journal of Medical Case Reports is committed to publish well
written case reports from around the world and be a source of inspiration for clinicians and
scientists about newer research directions.
Editorial
There has been a long descriptive history of case reporting
in relation to cancer. In his book titled Clinical Case Report-
ing in Evidence-Based Medicine, Milos Jenicek eloquently
describes case reports as the first line of evidence, where
everything begins [1]. Some of the earliest case reports
describing individual patients afflicted with cancer can be
traced all the way back to the papyrus records of Ancient
Egyptian medicine of approximately 1600 B.C.. These
reports were the first recorded cases of incurable tumors of
the breast [2]. Throughout the centuries physicians have
continued the practice of writing case reports. Case reports
of melanoma were described by Hippocrates in the fifth
century B.C. and also by Rufus of Ephesus, a Greek physi-
cian, in the first century A.C. [3].
Another area where case reporting has provided signifi-
cant advances in the knowledge of cancer has been in the
identification of new types of cancer. For example, in Jan-
uary 1832, Thomas Hodgkin reported six cases to the
Medical-Chirurgical Society of London, two of which were
what we know today as Hodgkin's lymphoma [4]. In
1957, while in Uganda, Dennis P. Burkitt described a
tumor that presented as a growth in the angle of the jaw
of African children [5], later to be known as Burkitt's lym-
phoma. In 1960, Peter Nowell and David Hungerford
published a report describing seven patients with chronic
myeloid leukemia having the same "minute chromo-
some" later to be known Philadelphia chromosome [6].
In 1990, Farcet et al. described two patients with a new
type of lymphoma, called Hepatosplenic T-Cell lym-
phoma [7], leading to more focused research of this new
entity.
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On the therapeutic front, the evolution of case reports to
describe treatment entities is still evolving. To date the
majority of reporting has been about adverse events. For
example a case report about a patient with acute myeloid
leukemia and nocardiosis revealed that high dose trimeth-
oprim-sulfamethoxazole is a direct cause of significant
myoclonus [8]. Another report revealed Aprepitant as a
cause of Ifosfamide-induced encephalopathy [9]. More
recently researchers have used the case report format to
share unusual treatment combinations or responses. For
example, Treon et al reported in 2004 about an interesting
clinical response to sildenafil in Waldenström's mac-
roglobulinemia [10].
It is without question that case reports do not replace well
designed randomized clinical trials in testing new thera-
peutics. However, in cancer therapeutics the numbers of
patients to conduct such studies may not be always
recruitable. The advancement of cancer knowledge relies
on a multitude of factors including molecular studies and
preclinical models in order to study disease mechanism
and potential targeted therapy: the kind of clinical infor-
mation that could be gained through a series of case
reports [11].
Another area where case reports about oncological mat-
ters have a role in the progress of medical science is in
medical education [12]. Journal of Medical Case Reports
(JMCR) is an open access journal that is committed to
publishing high quality case reports from anywhere in the
world and making them accessible to all. Through pro-
moting the role of case reports in oncology, we hope to
build a large prospective database of online case reports
that will add to the aspects of oncology described in the
evidence-based medical literature. This database will be a
future resource allowing researchers to ask specific ques-
tions and study characteristics of uncommon events.
JMCR will feed into an associated searchable database of
case reports, and this database will serve as a clearing
house of good case reports from all around the world. For
example, by publishing every case report about spontane-
ous regression of metastatic renal cell carcinoma after
debulking nephrectomy, a specific search of the database
would help researchers in studying this particular and
interesting phenomenon [13]. The prospective nature, of
course would be in the data collection not retrieval. The
planned aggregation of case reports has the potential to
contribute to the ability to study newer risk factors associ-
ated with cancer. We recognize that case reports can serve
as a substrate to further research many years after an orig-
inal publication. For example, in 1886, Felix Fränkel
described the first case report of pheochromocytoma in an
18 year-old woman with bilateral adrenal tumor. In 2007,
almost 121 years later, Neumann et al. studied four living
relatives of the same patient reported by Fränkel in 1886
and found that the patient had RET mutation and that her
family had multiple endocrine neoplasia (MEN-2) [14].
In Medicine, questions in "research" (looking back)
almost always start with patient encounters. Well written
case reports will always be a source of inspiration for cli-
nicians and scientists about newer research directions.
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